热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-mouse CD4 Antibody
产品名称：
Purified anti-mouse CD4 Antibody
产品类别：
抗体
产品编号：
100401
产品应用：
100401
[价格]
规格 价格 库存
50µg ￥ 288 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, IP - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation.?Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin < 0.01 EU/?g).

Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  13. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Zhang S, et al. 2017. Nature.. 10.1038/nature24283. PubMed
  2. Chami B, et al. 2017. Sci Rep. 7:10181. PubMed
  3. Tsukumo S, et al. 2006. J Immunol. 177:8365. PubMed
  4. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  5. Liao X, et al. 2022. Front Immunol. 12:768813. PubMed
  6. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  7. Hummel JF, et al. 2020. Mucosal Immunol. 0.720138889. PubMed
  8. Smith CJ, et al. 2018. J Immunol. 200:1580. PubMed
  9. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  10. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  11. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  12. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  13. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  14. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  15. Landuyt AE, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  16. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  17. Baja?a S, et al. 2021. Front Immunol. 11:577718. PubMed
  18. Murata A, et al. 2020. Front Immunol. 11:775. PubMed
  19. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  20. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  21. Duvvuri M, et al. 2019. Biomater Sci. 7:1863. PubMed
  22. Yang J, et al. 2020. Front Immunol. 10:3048. PubMed
  23. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  24. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  25. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  26. Hashimoto K, et al. 2021. J Dermatol Sci. 102:177. PubMed
  27. Haque M, et al. 2021. Viruses. 13:. PubMed
  28. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  29. Tian K, et al. 2021. J Immunol Res. 2021:6297332. PubMed
  30. Hirano J, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  31. Draganov D, et al. 2021. NPJ Breast Cancer. 7:22. PubMed
  32. Rossi DC, et al. 2021. J Clin Invest. 131:. PubMed
  33. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  34. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  35. Xie MM, et al. 2017. Eur J Immunol. 47:1136. PubMed
  36. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  37. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  38. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  39. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  40. Tan L, et al. 2017. Int J Nanomedicine. 12:3095. PubMed
  41. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  42. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  43. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  44. Lasrado N, et al. 2021. Microorganisms. 9:. PubMed
  45. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  46. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  47. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  48. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  49. Wang N, et al. 2021. Mol Ther Oncolytics. 20:71. PubMed
  50. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  51. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  52. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  53. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  54. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  55. Sharma M, et al. 2020. Nat Commun. 11:661. PubMed
  56. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  57. Overacre-Delgoffe AE, et al. 2017. Cell. 169:1130. PubMed
  58. Elsayed H, et al. 2018. J Virol. 92:e00428. PubMed
  59. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  60. Hu M, et al. 2008. J Immunol. 180:6593. PubMed
  61. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  62. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  63. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  64. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  65. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  66. Hsiao CC, et al. 2021. Cells. 10:. PubMed
  67. Horiuchi S, et al. 2021. Sci Immunol. :eabm3131. PubMed
  68. Kinosada H, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006120. PubMed
  69. Pierini A, et al. 2017. JCI Insight. 2. PubMed
  70. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  71. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  72. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  73. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  74. Majer O, et al. 2019. Nature. 575:366. PubMed
  75. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  76. Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
  77. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  78. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  79. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  80. Zhang H, et al. 2017. J Immunol. 198:2133. PubMed
  81. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  82. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  83. Zander R, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.10.077. PubMed
  84. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  85. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  86. Ikezoe T, et al. 2021. Biomolecules. 11:. PubMed
  87. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  88. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  89. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  90. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  91. Meyers JL, et al. 2018. PLoS One. 13:e0207007. PubMed
  92. Floudas A, et al. 2017. J Immunol. 199:707. PubMed
  93. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  94. Pradhan P, et al. 2017. JCI Insight. 2. PubMed
  95. Song K, et al. 2017. Oncotarget. 8:38554. PubMed
  96. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  97. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  98. Wilhelmson AS, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1519. PubMed
  99. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  100. Stefanski HE, et al. 2018. PLoS One. 13:e0198871. PubMed
  101. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  102. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  103. Tsai MS, et al. 2021. Int J Mol Sci. 22:. PubMed
  104. Zhang Z, et al. 2020. Front Immunol. 1.844444444. PubMed
  105. Rosenberg J, et al. 2020. Cell Systems. 10(5):433-444. PubMed
  106. Scutts SR, et al. 2018. Cell Rep. 25:1953. PubMed
  107. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  108. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  109. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  110. Luu M, et al. 2019. Nat Commun. 10:760. PubMed
  111. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  112. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  113. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  114. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  115. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  116. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  117. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  118. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  119. Zhang N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  120. Whittle JR, et al. 2020. Clin Cancer Res. 26:4120. PubMed
  121. Liu H, et al. 2022. Animal Model Exp Med. 5:72. PubMed
  122. Kr?mer TJ, et al. 2019. J Neuroinflammation. 16:163. PubMed
  123. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  124. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  125. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  126. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  127. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
RRID
AB_312686 (BioLegend Cat. No. 100401) AB_312687 (BioLegend Cat. No. 100402)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线